Literature DB >> 19271740

Technical and biological issues relevant to cell typing with aptamers.

Na Li1, Jessica N Ebright, Gwendolyn M Stovall, Xi Chen, Hong Hanh Nguyen, Amrita Singh, Angel Syrett, Andrew D Ellington.   

Abstract

A number of aptamers have been selected against cell surface biomarkers or against eukaryotic tissue culture cells themselves. To determine the general utility of aptamers for assessing the cell surface proteome, we developed a standardized flow cytometry assay and carried out a comprehensive study with 7 different aptamers and 14 different cell lines. By examining how aptamers performed with a variety of cell lines, we identified difficulties in using aptamers for cell typing. While there are some aptamers that show excellent correlation between cell surface binding and the expression of a biomarker on the cell surface, other aptamers showed nonspecific binding by flow cytometry. For example, it has recently been claimed that an anti-PTK7 (protein tyrosine kinase 7) aptamer identified a new biomarker for leukemia cells, but data with the additional cell lines shows that it is possible that the aptamer instead identifies a propensity for adherence. Better understanding and controlling for the role of background and nonspecific binding to cells should open the way to using arrays of aptamers for describing and quantifying the cell surface proteome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271740     DOI: 10.1021/pr801048z

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  35 in total

1.  Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures.

Authors:  Günter Mayer; Marie-Sophie L Ahmed; Andreas Dolf; Elmar Endl; Percy A Knolle; Michael Famulok
Journal:  Nat Protoc       Date:  2010-12-02       Impact factor: 13.491

Review 2.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

3.  In vitro selection with artificial expanded genetic information systems.

Authors:  Kwame Sefah; Zunyi Yang; Kevin M Bradley; Shuichi Hoshika; Elizabeth Jiménez; Liqin Zhang; Guizhi Zhu; Savita Shanker; Fahong Yu; Diane Turek; Weihong Tan; Steven A Benner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

4.  Strategies for the discovery of therapeutic aptamers.

Authors:  Xianbin Yang; Na Li; David G Gorenstein
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

Review 5.  Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement.

Authors:  Amy C Yan; Matthew Levy
Journal:  Nucleic Acid Ther       Date:  2018-06       Impact factor: 5.486

6.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

7.  Next-generation sequencing as input for chemometrics in differential sensing routines.

Authors:  Sara Goodwin; Alexandra M Gade; Michelle Byrom; Baine Herrera; Camille Spears; Eric V Anslyn; Andrew D Ellington
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-31       Impact factor: 15.336

Review 8.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

Review 9.  Aptamers and aptamer targeted delivery.

Authors:  Amy C Yan; Matthew Levy
Journal:  RNA Biol       Date:  2009-07-18       Impact factor: 4.652

10.  Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer.

Authors:  Parag Parekh; Sanchit Kamble; Nianxi Zhao; Zihua Zeng; Bryce P Portier; Youli Zu
Journal:  Biomaterials       Date:  2013-08-19       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.